Ipilimumab is available as a 5-mg/mL concentrate for injection in 10- and 40-mL preservative-free, single-dose vials.3880 Each mL of the concentrate contains ipilimumab 5 mg with pentetic acid 0.04 mg, mannitol 10 mg, polysorbate 80 0.1 mg, sodium chloride 5.85 mg, and tris hydrochloride 3.15 mg in water for injection.3880
The concentrate must be diluted prior to administration.3880 Prior to use, allow vials to stand at room temperature for approximately 5 minutes.3880 To prepare the drug for intravenous infusion, the appropriate dose of the concentrate should be withdrawn from the vial and added to an infusion bag followed by a volume of dextrose 5% or sodium chloride 0.9% to yield a final ipilimumab concentration between 1 and 2 mg/mL.3880 The solution should be mixed by gentle inversion.3880 Any unused portion remaining in vials should be discarded.3880
pH
7.3880
Trade Name(s)
Yervoy
Ipilimumab is administered by intravenous infusion over 30 or 90 minutes only after dilution in dextrose 5% or sodium chloride 0.9%.3880 Diluted solutions for infusion should be administered through a low protein-binding inline filter.3880 The infusion line should be flushed with dextrose 5% or sodium chloride 0.9% after each infusion.3880
Other drugs should not be co-administered with ipilimumab through the same infusion line.3880
Intact vials of ipilimumab should be stored at 2 to 8°C in the original carton to protect from light and should not be shaken or frozen.3880 The concentrate for injection is a clear to slightly opalescent, colorless to pale yellow solution that may contain a small amount of visible translucent to white amorphous particles.3880 Vials should be visually inspected for particulate matter and discoloration prior to use; discard the solution if it is discolored, cloudy, or if particulate matter other than translucent to white amorphous particles is present.3880
The manufacturer states diluted solutions may be stored for up to 24 hours at room temperature or 2 to 8°C.3880
Filtration
Diluted solutions for infusion should be administered through a low protein-binding inline filter.3880
For a list of references cited in the text of this monograph, search the monograph titled References.